MicroRNAs and lung cancers: from pathogenesis to clinical implications

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Lung cancer remains a primary cause of cancer mortality globally.
• Improved understanding of lung cancer pathogenesis is crucial for enhanced clinical management.
• Small non-coding RNAs, specifically microRNAs, are critical posttranscriptional gene regulators.

Purpose of the Study:

• To summarize the roles of microRNAs in lung cancer development.
• To discuss microRNAs with oncogenic and tumor-suppressive functions in lung cancer.
• To explore the potential of microRNAs as biomarkers and therapeutic targets for lung cancer.

Main Methods:

• Literature review and synthesis of existing research on microRNAs in lung cancer.
• Analysis of studies detailing microRNA functions in lung cancer pathogenesis.
• Examination of data regarding microRNA utility in diagnosis, prognosis, and therapy.

Main Results:

• MicroRNAs significantly influence lung cancer progression through both oncogenic and tumor-suppressive mechanisms.
• Specific microRNAs have been identified that promote or inhibit tumor growth.
• MicroRNAs demonstrate potential as diagnostic and prognostic markers.
• MicroRNA-based therapies are an emerging and promising area for lung cancer treatment.

Conclusions:

• MicroRNAs are integral to lung cancer pathogenesis, acting as both oncogenes and tumor suppressors.
• MicroRNAs hold significant promise as biomarkers for early detection and prognosis.
• Targeting microRNAs represents a novel and developing therapeutic avenue for lung cancer treatment.